CORONARY ARTERY DISEASE IN LOW- TO INTERMEDIATE-RISK ASYMPTOMATIC PEOPLE WITH HIV: COMPARISON TO ASYMPTOMATIC COMMUNITY AND STABLE CHEST PAIN POPULATIONS WITHOUT KNOWN HIV
Júlia Karády(Semmelweis University), Pamela S. Douglas(Duke University), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Göran Bergström(Sahlgrenska University Hospital), Lars Lind(Uppsala University), David Mushatt(Tulane University), Udo Hoffmann(Duke Medical Center), Rosalie Pepe(Cooper University Hospital), Jana Taron(University Medical Center Freiburg), Tomas Jernberg(Karolinska Institutet), Stefan Söderberg(Umeå University), Borek Foldyna(Cancer Research And Biostatistics), Kayla Paradis(Cancer Research And Biostatistics), Thomas Mayrhofer(Harvard University), Steven Grinspoon(Massachusetts General Hospital), Michael T. Lu(Cancer Research And Biostatistics), Olof Elvstam(Malmö University), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Gerald S. Bloomfield, Judith S. Currier(University of California, Los Angeles), Kathleen V. Fitch(Harvard University), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Markella V. Zanni(Harvard University), Michael P. Dubé(Indiana University School of Medicine), Heather J. Ribaudo(Cancer Research And Biostatistics)
Cited by 1
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2012|2.3k